| Financial Year |
March 31 2023 |
| Monetary Funds |
443,433,725.07 |
| Held-for-trading Financial Assets |
240,677,346.03 |
| Notes Receivable |
149,337,443.25 |
| Accounts Receivable |
248,989,325.11 |
| Advances to Suppliers |
49,813,928.53 |
| Other Receivables |
10,404,584.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
413,815,824.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,776,944.23 |
| Total Current Assets |
1,587,912,421.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
192,504,030.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,537,955.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
114,070.22 |
| Deferred Income Tax Assets |
27,283,522.06 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
277,244,614.56 |
| Total Assets |
1,865,157,035.93 |
| Short-Term Loans |
3,003,291.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
138,672,380.45 |
| Accounts Payable |
170,963,825.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
-- |
| Taxes Payable |
6,665,371.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,106,653.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
452,653.88 |
| Other Current Liabilities |
30,304,033.13 |
| Sub-Total of Current Liabilities |
573,969,797.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,131,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,478,148.57 |
| Total Liabilities |
578,447,946.42 |
| Paid-In Capital(Or Share Stock) |
588,615,750.00 |
| Capital Surplus |
424,574,892.85 |
| Surplus Reserve |
82,039,480.08 |
| LESS:Treasury Stock |
25,076,681.29 |
| Undistributed Profits |
129,126,644.47 |
| Minority Stockholder's Interest |
85,513,065.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,201,196,024.18 |
| Owner's Equity（Stockholder's Equity） |
1,286,709,089.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,865,157,035.93 |
